These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 29627111)
1. In-Stent Restenosis of Drug-Eluting Stents Compared With a Matched Group of Patients With De Novo Coronary Artery Stenosis. Buchanan KD; Torguson R; Rogers T; Xu L; Gai J; Ben-Dor I; Suddath WO; Satler LF; Waksman R Am J Cardiol; 2018 Jun; 121(12):1512-1518. PubMed ID: 29627111 [TBL] [Abstract][Full Text] [Related]
3. Comparison of 2-year outcomes of repeated second-generation drug-eluting stent implantation for focal-type versus nonfocal-type in-stent restenosis. Zhu W; Li J; Luo H; Wang G; Hua Q Coron Artery Dis; 2015 Nov; 26(7):587-91. PubMed ID: 26166020 [TBL] [Abstract][Full Text] [Related]
4. Efficacy of drug-eluting stents for treating in-stent restenosis of drug-eluting stents (from the Korean DES ISR multicenter registry study [KISS]). Ko YG; Kim JS; Kim BK; Choi D; Hong MK; Jeon DW; Yang JY; Ahn YK; Jeong MH; Yu CW; Yun KH; Lim DS; Jang Y; Am J Cardiol; 2012 Mar; 109(5):607-13. PubMed ID: 22172241 [TBL] [Abstract][Full Text] [Related]
5. Long-Term Clinical Outcomes After Bioresorbable Vascular Scaffold Implantation for the Treatment of Coronary In-Stent Restenosis: A Multicenter Italian Experience. Moscarella E; Ielasi A; Granata F; Coscarelli S; Stabile E; Latib A; Cortese B; Tespili M; Tanaka A; Capozzolo C; Caliendo L; Colombo A; Varricchio A Circ Cardiovasc Interv; 2016 Apr; 9(4):e003148. PubMed ID: 27059683 [TBL] [Abstract][Full Text] [Related]
6. Clinical outcome of percutaneous treatment of in-stent restenosis with drug-eluting stents: results from the first phase of the prospective multicentre German DES.DE registry. Abdel-Wahab M; Nienaber CA; Mostafa AE; Sabin G; Tebbe U; Hochadel M; Senges J; Akin I; Kuck KH; Hamm C; Richardt G; EuroIntervention; 2011 Jun; 7(2):201-8. PubMed ID: 21646062 [TBL] [Abstract][Full Text] [Related]
7. Clinical outcomes of the Resolute zotarolimus-eluting stent in patients with in-stent restenosis: 2-year results from a pooled analysis. Richardt G; Leschke M; Abdel-Wahab M; Toelg R; El-Mawardy M; Serruys PW; Silber S; Windecker S; Belardi JA; Neumann FJ; Widimsky P; ; JACC Cardiovasc Interv; 2013 Sep; 6(9):905-13. PubMed ID: 23954063 [TBL] [Abstract][Full Text] [Related]
8. Everolimus-Eluting Stents in Patients With Bare-Metal and Drug-Eluting In-Stent Restenosis: Results From a Patient-Level Pooled Analysis of the RIBS IV and V Trials. Alfonso F; Pérez-Vizcayno MJ; García Del Blanco B; García-Touchard A; López-Mínguez JR; Masotti M; Zueco J; Melgares R; Mainar V; Moreno R; Domínguez A; Sanchís J; Bethencourt A; Moreu J; Cequier A; Martí V; Otaegui I; Bastante T; Gonzalo N; Jiménez-Quevedo P; Cárdenas A; Fernández C; Circ Cardiovasc Interv; 2016 Jul; 9(7):. PubMed ID: 27412868 [TBL] [Abstract][Full Text] [Related]
9. Comparison of outcomes after treatment of in-stent restenosis using newer generation drug-eluting stents versus drug-eluting balloon: Patient-level pooled analysis of Korean Multicenter in-Stent Restenosis Registry. Lee JM; Rhee TM; Hahn JY; Hwang D; Park J; Park KW; Kim HL; Kim SH; Chae IH; Doh JH; Jeon KH; Choi YJ; Park JS; Choi SH; Gwon HC; Koo BK; Alfonso F; Kim HS Int J Cardiol; 2017 Mar; 230():181-190. PubMed ID: 28043660 [TBL] [Abstract][Full Text] [Related]
10. A comparison of procedural success rate and long-term clinical outcomes between in-stent restenosis chronic total occlusion and de novo chronic total occlusion using multicenter registry data. Lee SH; Cho JY; Kim JS; Lee HJ; Yang JH; Park JH; Hong SJ; Choi RK; Choi SH; Gwon HC; Lim DS; Yu CW Clin Res Cardiol; 2020 May; 109(5):628-637. PubMed ID: 31552494 [TBL] [Abstract][Full Text] [Related]
11. Effectiveness of everolimus-eluting stents in the treatment of drug-eluting stent versus bare-metal stent restenosis. Almalla M; Pross V; Marx N; Hoffmann R Coron Artery Dis; 2012 Nov; 23(7):492-6. PubMed ID: 22990414 [TBL] [Abstract][Full Text] [Related]
12. Long-term outcomes after the percutaneous treatment of drug-eluting stent restenosis. Latib A; Mussardo M; Ielasi A; Tarsia G; Godino C; Al-Lamee R; Chieffo A; Airoldi F; Carlino M; Montorfano M; Colombo A JACC Cardiovasc Interv; 2011 Feb; 4(2):155-64. PubMed ID: 21349453 [TBL] [Abstract][Full Text] [Related]
13. Outcome differences with the use of drug-eluting stents for the treatment of in-stent restenosis of bare-metal stents versus drug-eluting stents. Steinberg DH; Gaglia MA; Pinto Slottow TL; Roy P; Bonello L; De Labriolle A; Lemesle G; Torguson R; Kineshige K; Xue Z; Suddath WO; Kent KM; Satler LF; Pichard AD; Lindsay J; Waksman R Am J Cardiol; 2009 Feb; 103(4):491-5. PubMed ID: 19195508 [TBL] [Abstract][Full Text] [Related]
14. Comparison between drug-coated balloon angioplasty and second-generation drug-eluting stent placement for the treatment of in-stent restenosis after drug-eluting stent implantation. Kang IS; Shehata I; Shin DH; Kim JS; Kim BK; Ko YG; Choi D; Jang Y; Hong MK Heart Vessels; 2016 Sep; 31(9):1405-11. PubMed ID: 26337620 [TBL] [Abstract][Full Text] [Related]
15. Impact of coronary anatomy and stenting technique on long-term outcome after drug-eluting stent implantation for unprotected left main coronary artery disease. Tiroch K; Mehilli J; Byrne RA; Schulz S; Massberg S; Laugwitz KL; Vorpahl M; Seyfarth M; Kastrati A; JACC Cardiovasc Interv; 2014 Jan; 7(1):29-36. PubMed ID: 24332416 [TBL] [Abstract][Full Text] [Related]
16. Outcomes of Percutaneous Coronary Intervention for In-Stent Restenosis Versus De Novo Lesions: A Meta-Analysis. Elbadawi A; Dang AT; Mahana I; Elzeneini M; Alonso F; Banerjee S; Kumbhani DJ; Elgendy IY; Mintz GS J Am Heart Assoc; 2023 Jul; 12(13):e029300. PubMed ID: 37382147 [TBL] [Abstract][Full Text] [Related]
17. Clinical outcomes in the percutaneous coronary intervention of in-stent restenosis with everolimus-eluting stents. Lee MS; Yang T; Mahmud E; Park KW; Kim HS; Kim MH; Dangas G; Hermiller J; Krucoff M; Rutledge D J Invasive Cardiol; 2014 Sep; 26(9):420-6. PubMed ID: 25198484 [TBL] [Abstract][Full Text] [Related]
18. Long-Term Follow-Up After Treatment of Drug-Eluting Stent Restenosis and De Novo Lesions Using SeQuent Please Paclitaxel-Coated Balloons. Zhang D; Sun Y; Liu X; Liu F; Cheng Y; Ma X; Zhao Y; Zhou Y Angiology; 2019 May; 70(5):414-422. PubMed ID: 30384776 [TBL] [Abstract][Full Text] [Related]
19. Long-term Safety and Efficacy of New-Generation Drug-Eluting Stents in Women With Acute Myocardial Infarction: From the Women in Innovation and Drug-Eluting Stents (WIN-DES) Collaboration. Giustino G; Harari R; Baber U; Sartori S; Stone GW; Leon MB; Windecker S; Serruys PW; Kastrati A; Von Birgelen C; Kimura T; Stefanini GG; Dangas GD; Wijns W; Steg PG; Morice MC; Camenzind E; Weisz G; Smits PC; Sorrentino S; Sharma M; Farhan S; Faggioni M; Kandzari D; Galatius S; Jeger RV; Valgimigli M; Itchhaporia D; Mehta L; Kim HS; Chieffo A; Mehran R JAMA Cardiol; 2017 Aug; 2(8):855-862. PubMed ID: 28658478 [TBL] [Abstract][Full Text] [Related]
20. Acute coronary syndrome - a frequent clinical manifestation of bare metal in-stent restenosis. Drozd J; Wójcik J; Małek R; Korona B; Zapolski T; Wysokiński A Kardiol Pol; 2010 Jun; 68(6):637-45. PubMed ID: 20806192 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]